Source evidence
Backers
V-Bio Ventures
Active Belgian life sciences VC investing in biotech and drug development companies.
Something wrong or missing? Send an update. Fixed within 24 hours.
D
AgomAb Therapeutics Series B
Company-issued Business Wire release syndicated by PharmiWeb states $74m Series B close.